Report summary
HIV infection
The trend of decreasing reported HIV cases will continue in Norway in 2019, especially among men who have sex with infected men (MSM) living in Norway. Among heterosexually infected people, HIV rates have changed little. As of 2018, but both among people infected heterosexually while in Norway. As well as among people infected heterosexually before arriving in Norway. HIV infection rates have declined in recent years. And there is still a stable, low incidence of HIV. Among people taking drugs with syringes, women born in Norway and youth. MSM and heterosexual men traveling abroad, especially to Southeast Asia, continue to be most at risk of HIV infection.
2019 Annual Report on Infections. Gonorrhea
After several years of continued increases, gonorrhea rates among MSM declined slightly in 2019 but remain high. Among heterosexual women and men, gonorrhea continued to increase in 2019. Among women, the number of reported cases of gonorrhea increased tenfold in 10 years. However, among heterosexually infected people, more cases are currently detected among women than men. Situation in Norway follows internationally a trend in which gonorrhea is rising rapidly in many Western countries.
Syphilis
Since the late 90s, the incidence of syphilis among MSM has increased significantly in Norway, and as a result, cases diagnosed have decreased somewhat in 2019. However, most MSM is still infected through casual sex in Oslo, however, development in recent years with more infections in the rest of Norway, especially in larger cities such as Bergen, Trondheim and Stavanger, or during holiday trips to larger European cities. Migrant MSM and HIV positive people in particular are at risk of contracting syphilis. The prevalence of syphilis is now much higher among heterosexual men and women. Compared to the previous 10 years, but has remained fairly stable in recent years. The last case of congenital syphilis was reported to MSIS in 2003.
Chlamydia
The reported incidence of chlamydia increased annually from the turn of the millennium to 2008. However, it remained stable with slight changes over the next 10 years. For example, in 2019, 28 cases were diagnosed, 466 per 534 inhabitants. This represents an increase of 100% compared to last year and the highest observation so far. In particular, in the last year, there has been an increase in the 000-6,6 age group. The number of respondents in 20 amounted to 24, which means an increase in the number of respondents by 2019% from 386,978. 6,3% of respondents were diagnosed with chlamydia in 2018.
Lymphogranuloma venerum
Lymphogranuloma venerum (LGV) is a sexually transmitted infection caused by infection with a different serotype (L1, L2, L3) of chlamydia (Chlamydia trachomatis) than common chlamydia infection. The National Institute of Public Health has been providing LGV monitoring data since 2012. The number of cases reported annually ranged from 13–44. In 2019, 27 LGV cases were reported in Norway, compared with 44 in 2018. All cases in 2019 belonged to MSM.
